High‐dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre
The DOI matches its Crossref record.
Abstract
The aim of this study was to investigate the efficacy of riboflavin for the prevention of migraine. An open label study was performed in a specialized outpatient clinic. Patients received 400 mg riboflavin capsules per day. Headache frequency, duration, intensity and the use of abortive drugs were recorded at baseline and 3 and 6 months after treatment. Headache frequency was significantly reduced from 4 days/month at baseline to 2 days/month after 3 and 6 months (P < 0.05). The use of abortive drugs decreased from 7 units/month to 4.5 units/month after 3 and 6 months of treatment (P < 0.05). In contrast, headache hours and headache intensity did not change significantly. We could demonstrate a significant reduction of headache frequency following riboflavin treatment. In addition, the number of abortive anti‐migraine tablets was reduced. In line with previous studies our findings show that riboflavin is a safe and well‐tolerated alternative in migraine prophylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
The metabolic face of migraine — from pathophysiology to treatment
Gross, E. C., Lisicki, M., Fischer, D., Sándor, P. S., & Schoenen, J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0255-4 · Cited by 262
Venkatesan, T., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., Stave, C. D., Sharaf, R. N., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13604 · Cited by 137
Prophylaxis of migraine headaches with riboflavin: A systematic review
Thompson, D. F., & Saluja, H. S. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12548 · Cited by 101
Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study
Boles, R. G., Lovett-Barr, M. R., Preston, A., Li, B. U., & Adams, K. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-10 · Cited by 91
“Additional mitochondrial-targeted dietary supplements have also been used to prevent CVS attacks including L-carnitine, which has demonstrated efficacy in CVS in one small openlabel study [31] (authors’ practice: 100 mg/kg/day divided BID, up to one gram BID or TID), and riboflavin, which has demonstrated efficacy in…”
Metadata
- Authors
- Boehnke, C., Reuter, U., Flach, U., Schuh‐Hofer, S., Einhäupl, K. M., & Arnold, G.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2004-07
- Volume
- 11
- Issue
- 7
- Pages
- 475-477
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2132891002
- Cited by
- 200
- References
- 0
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High‐dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. https://app.cochat.ai/papers/10.1111/j.1468-1331.2004.00813.x
- The paper
- Boehnke, C., Reuter, U., Flach, U., Schuh‐Hofer, S., Einhäupl, K. M., & Arnold, G. (2004). High‐dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2004.00813.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.